Loxo Oncology
Biotechnology ResearchConnecticut, United States11-50 Employees
Loxo Oncology develops oncological drugs for well-defined patient groups, whose cancers share common genetic drivers.
Precision Medicine Focus Loxo Oncology develops oncological drugs targeting specific genetic drivers, presenting a strong value proposition for precision medicine sales strategies.
Competitive Positioning In a market with similar companies like Schrödinger and Deciphera Pharmaceuticals, Loxo Oncology's niche focus on genetic-driven cancers can be leveraged as a unique selling point for differentiation.
Tech-Forward Approach Utilizing technologies like Oracle and Microsoft showcases Loxo Oncology as a technologically advanced company, appealing to prospects seeking innovative solutions in oncology research.
Strategic Location Being headquartered in Stamford, CT, a hub for biotechnology research, allows Loxo Oncology to tap into a vibrant ecosystem, presenting networking and collaboration opportunities for sales expansion.
Sales Alignment Opportunities With a moderate workforce size of 11-50 employees, there is potential for focused sales enablement strategies and personalized engagement tactics to drive business growth and customer acquisition for Loxo Oncology.
Loxo Oncology uses 8 technology products and services including Oracle, Typekit, Microsoft, and more. Explore Loxo Oncology's tech stack below.
Loxo Oncology Email Formats | Percentage |
FLast@loxooncology.com | 90% |
First.Last@loxooncology.com | 5% |
First@loxooncology.com | 4% |
Last@loxooncology.com | 1% |
Biotechnology ResearchConnecticut, United States11-50 Employees
Loxo Oncology develops oncological drugs for well-defined patient groups, whose cancers share common genetic drivers.